On the other hand, the study did not show meaningful differences between AML patients compared to healthy volunteers for TRAIL: 68.54 pg/ml (19.1–104.8 pgml) versus 79.9 pg/ml (55.4–108.2 pg/ml), p = 0.12 (Table 2). The gene discussed is TNFSF10; the disease is acute myeloid leukemia.